Schenkein David P

CIK 00015782006 companiesTARRYTOWN, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001578200

Recent Transactions

50 trades

Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2026-01-02+155→ 603 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2026-01-02+1,962→ 1,962 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01+45,000→ 45,000 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01+39,062→ 39,062 total
Disposition to Issuer
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01−45,000→ 0 total
Disposition to Issuer
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01−39,062→ 0 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-06-04+55,000→ 55,000 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2025-06-03+6,037→ 15,257 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2025-06-03+18,111→ 18,111 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-01-02+166→ 448 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2025-01-02+1,958→ 1,958 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-11$32.09/sh−27,129→ 41,532 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-11-11−47,165→ 0 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-11$32.87/sh−32,312→ 9,220 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-11$18.00/sh+47,165→ 68,661 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-20+2,120→ 2,120 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2024-06-20+11,774→ 11,774 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-06-13+3,388→ 126,242 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-13−3,388→ 0 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2024-06-12+45,000→ 45,000 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-05-31+17,901→ 17,901 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2024-05-31+5,967→ 21,496 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-02-27$31.64/sh+57,471→ 180,325 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-02-27$33.60/sh−11,858→ 122,854 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2024-02-27−57,471→ 0 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-02-27$34.89/sh−57,471→ 122,854 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-02-27$31.64/sh+11,858→ 134,712 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2024-02-27−11,858→ 57,471 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-02-26$33.19/sh−20,411→ 122,854 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2024-02-26−20,411→ 69,329 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-02-26$31.64/sh+20,411→ 143,265 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2024-02-23−47,731→ 89,740 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-02-23$33.05/sh−47,731→ 122,854 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-02-23$31.64/sh+47,731→ 170,585 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-02+42→ 282 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-02+508→ 508 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-09-08+240→ 240 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-09-08+2,739→ 2,739 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2023-06-21−4,975→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-06-21+4,975→ 122,854 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2023-06-14+39,062→ 39,062 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2023-06-13+18,958→ 18,958 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2023-06-13+3,388→ 3,388 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-06-01+12,649→ 12,649 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2023-06-01+4,216→ 15,529 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2023-04-03−16,363→ 0 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-04-03$22.85/sh−16,363→ 117,879 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-04-03$9.05/sh+16,363→ 134,242 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2023-03-27−20,000→ 16,363 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-03-27$9.05/sh+20,000→ 137,879 total

Companies

Recent Filings

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591

View on SEC.gov